Metabolic Engineering of Yarrowia lipolytica for De Novo Biosynthesis of Umbelliferone
Biomolecules · 2026
DOI: 10.3390/biom16101450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Fengliu Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Bio-Energy Crops, School of Life Sciences, Shanghai University, Shanghai 200444, China. Hauptthemen laut MEDLINE: Umbelliferones, Yarrowia, Metabolic Engineering. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hefei Biosynthesis Technology Co., Ltd of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Umbelliferone, a key precursor for the biosynthesis of high-value furanocoumarin derivatives, is produced via the shikimate pathway. The oleaginous yeast Yarrowia lipolytica possesses an inherently robust shikimate pathway; however, de novo biosynthesis of umbelliferone in this microbial chassis has not been realized to date. Low intracellular pools of p-coumaric acid and suboptimal catalytic activity of downstream hydroxylation and cyclization enzymes represent the major bottlenecks limiting efficient umbelliferone production. In this study, we systematically screened five PAL/TAL variants, three 4CL isoforms, and two C2′H enzymes derived from diverse plant and microbial sources. The bifunctional enzyme RtPAL-TAL exhibited the highest productivity of p-coumaric acid, while the combination of At4CL3 and RgC2′H achieved the maximum umbelliferone accumulation. Expression of feedback-insensitive shikimate pathway mutant enzymes effectively relieved intrinsic pathway feedback inhibition, resulting in a 10.2-fold improvement in p-coumaric acid titer. All synthetic biosynthetic gene cassettes were stably integrated into the Y. lipolytica genome to generate the engineered strain YL-PU, which yielded 3.29 mg/L umbelliferone in shake-flask cultures. Further fed-batch fermentation in a 5 L bioreactor increased the umbelliferone titer to 125.52 mg/L at 84 h of cultivation. This work establishes the first de novo umbelliferone biosynthesis pathway in Y. lipolytica and identifies that C2′H represents a major candidate bottleneck under the tested configuration, in agreement with earlier findings. These findings provide a robust foundation for further metabolic engineering of the Y. lipolytica chassis to enable high-titer production of coumarins and other phenylpropanoid natural products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Bio-Energy Crops, School of Life Sciences, Shanghai University, Shanghai 200444, China.
ORCID-Profile: Yansheng Zhang
Förderung
- Hefei Biosynthesis Technology Co., Ltd of China
- National Key Research and Development Program of China
Zitieren
APA
Lu, F., Luo, Y., Lei, Z., Li, C., & Zhang, Y. (2026). Metabolic Engineering of Yarrowia lipolytica for De Novo Biosynthesis of Umbelliferone. Biomolecules. https://doi.org/10.3390/biom16101450
Vancouver
Lu F, Luo Y, Lei Z, Li C, Zhang Y. Metabolic Engineering of Yarrowia lipolytica for De Novo Biosynthesis of Umbelliferone. Biomolecules. 2026. doi:10.3390/biom16101450
BibTeX
@article{Lu2026,
author = {Lu, Fengliu and Luo, Ying and Lei, Zhen and Li, Changfu and Zhang, Yansheng},
title = {Metabolic Engineering of Yarrowia lipolytica for De Novo Biosynthesis of Umbelliferone},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16101450}
}
EUVIMED